<VariationArchive VariationID="684775" VariationName="NM_007055.4(POLR3A):c.3583del (p.Asp1195fs)" VariationType="Deletion" Accession="VCV000684775" Version="7" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-06-23" DateCreated="2019-09-01" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="672363" VariationID="684775">
      <GeneList>
        <Gene Symbol="POLR3A" FullName="RNA polymerase III subunit A" GeneID="11128" HGNC_ID="HGNC:30074" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>10q22.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="77975149" stop="78029515" display_start="77975149" display_stop="78029515" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="79734906" stop="79789297" display_start="79734906" display_stop="79789297" Strand="-" />
          </Location>
          <OMIM>614258</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_007055.4(POLR3A):c.3583del (p.Asp1195fs)</Name>
      <CanonicalSPDI>NC_000010.11:77982663:CC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>10q22.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="77982664" stop="77982664" display_start="77982664" display_stop="77982664" variantLength="1" positionVCF="77982663" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="79742422" stop="79742422" display_start="79742422" display_stop="79742422" variantLength="1" positionVCF="79742421" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
      </Location>
      <OtherNameList>
        <Name>NM_007055.4(POLR3A):c.3583del</Name>
        <Name>p.Asp1195fs</Name>
      </OtherNameList>
      <ProteinChange>D1195fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.10" sequenceAccession="NC_000010" sequenceVersion="10" change="g.79742423del" Assembly="GRCh37">
            <Expression>NC_000010.10:g.79742423del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.11" sequenceAccession="NC_000010" sequenceVersion="11" change="g.77982665del" Assembly="GRCh38">
            <Expression>NC_000010.11:g.77982665del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_029648.1" sequenceAccession="NG_029648" sequenceVersion="1" change="g.51877del">
            <Expression>NG_029648.1:g.51877del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_007055.4" sequenceAccession="NM_007055" sequenceVersion="4" change="c.3583del" MANESelect="true">
            <Expression>NM_007055.4:c.3583del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_008986.2" sequenceAccession="NP_008986" sequenceVersion="2" change="p.Asp1195fs">
            <Expression>NP_008986.2:p.Asp1195fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="747683665" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_007055.4(POLR3A):c.3583del (p.Asp1195fs) AND Leukoencephalopathy-ataxia-hypodontia-hypomyelination syndrome" Accession="RCV000845271" Version="5">
        <ClassifiedConditionList TraitSetID="7457">
          <ClassifiedCondition DB="MedGen" ID="C2676243">Leukoencephalopathy-ataxia-hypodontia-hypomyelination syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-01-24" SubmissionCount="2">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_007055.4(POLR3A):c.3583del (p.Asp1195fs) AND not provided" Accession="RCV001858455" Version="3">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_007055.4(POLR3A):c.3583del (p.Asp1195fs) AND POLR3A-related disorder" Accession="RCV002442785" Version="1">
        <ClassifiedConditionList TraitSetID="81106">
          <ClassifiedCondition>POLR3A-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-11-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-01-24" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2019-09-01" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21855841</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25339210</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27612211</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30414627</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30450527</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32582862</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">614258</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">22855961</ID>
          <ID Source="BookShelf">NBK99167</ID>
        </Citation>
        <DescriptionHistory Dated="2023-02-02">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="81106" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="66321" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">POLR3A-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">POLR3A-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">POLR3A-related disorders</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="7457" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5403" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION</ElementValue>
                <XRef Type="MIM" ID="607694" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION</ElementValue>
                <XRef Type="MIM" ID="607694" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM</ElementValue>
                <XRef Type="MIM" ID="607694" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614258.0001" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dentoleukoencephalopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dentoleukoencephalopathy, autosomal recessive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hypomyelinating leukodystrophy 7</ElementValue>
                <XRef ID="Leukodystrophy+with+oligodontia/4200" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Leukoencephalopathy-ataxia-hypodontia-hypomyelination syndrome</ElementValue>
                <XRef ID="MONDO:0011897" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OLIGODONTIA</ElementValue>
                <XRef Type="Allelic variant" ID="614258.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614258.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614258.0005" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OLIGODONTIA AND HYPOGONADOTROPIC HYPOGONADISM</ElementValue>
                <XRef Type="Allelic variant" ID="614258.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614258.0004" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">LEUKODYSTROPHY, HYPOMYELINATING, 7, WITHOUT OLIGODONTIA OR HYPOGONADOTROPIC HYPOGONADISM</ElementValue>
                <XRef Type="Allelic variant" ID="614258.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614258.0006" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leukodystrophy, hypomyelinating, with hypodontia and hypogonadotropic hypogonadism</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">4h syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HLD7</ElementValue>
                <XRef Type="MIM" ID="607694" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ADDH</ElementValue>
                <XRef Type="MIM" ID="607694" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16948" />
                <XRef ID="16948" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">POLR3-related leukodystrophy, a hypomyelinating leukodystrophy with specific features on brain MRI, is characterized by varying combinations of four major clinical findings: Neurologic dysfunction, typically predominated by motor dysfunction (progressive cerebellar dysfunction, and to a lesser extent extrapyramidal [i.e., dystonia], pyramidal [i.e., spasticity] and cognitive dysfunctions). Abnormal dentition (delayed dentition, hypodontia, oligodontia, and abnormally placed or shaped teeth). Endocrine abnormalities such as short stature (in ~50% of individuals) with or without growth hormone deficiency, and more commonly, hypogonadotropic hypogonadism manifesting as delayed, arrested, or absent puberty. Ocular abnormality in the form of myopia, typically progressing over several years and becoming severe. POLR3-related leukodystrophy and 4H leukodystrophy are the two recognized terms for five previously described overlapping clinical phenotypes (initially described as distinct entities before their molecular basis was known). These include: Hypomyelination, hypodontia, hypogonadotropic hypogonadism (4H syndrome); Ataxia, delayed dentition, and hypomyelination (ADDH); Tremor-ataxia with central hypomyelination (TACH); Leukodystrophy with oligodontia (LO); Hypomyelination with cerebellar atrophy and hypoplasia of the corpus callosum (HCAHC). Age of onset is typically in early childhood but later-onset cases have also been reported. An infant with Wiedemann-Rautenstrauch syndrome (neonatal progeroid syndrome) was recently reported to have pathogenic variants in POLR3A on exome sequencing. Confirmation of this as a very severe form of POLR3-related leukodystrophy awaits replication in other individuals with a clinical diagnosis of Wiedemann-Rautenstrauch syndrome.</Attribute>
                <XRef ID="NBK99167" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22855961</ID>
                <ID Source="BookShelf">NBK99167</ID>
              </Citation>
              <XRef ID="137639" DB="Orphanet" />
              <XRef ID="447893" DB="Orphanet" />
              <XRef ID="447896" DB="Orphanet" />
              <XRef ID="77295" DB="Orphanet" />
              <XRef ID="88637" DB="Orphanet" />
              <XRef ID="C2676243" DB="MedGen" />
              <XRef ID="MONDO:0011897" DB="MONDO" />
              <XRef Type="MIM" ID="607694" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1935629" SubmissionDate="2019-08-16" DateLastUpdated="2019-09-01" DateCreated="2019-09-01">
        <ClinVarSubmissionID localKey="NM_007055.3:c.3583delG|LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM;HLD7" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000987276" DateUpdated="2019-09-01" DateCreated="2019-09-01" Type="SCV" Version="1" SubmitterName="MyeliNeuroGene Lab, McGill University Health Center Research Institute" OrgID="320379" OrganizationCategory="laboratory" OrgAbbreviation="MNG" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">614258</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POLR3A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_007055.3:c.3583delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM</ElementValue>
            </Name>
          </Trait>
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">HLD7</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6186611</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5239735" SubmissionDate="2022-11-18" DateLastUpdated="2022-11-29" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="NM_007055.4:c.3583del|POLR3A-related disorders" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002754527" DateUpdated="2022-11-29" DateCreated="2022-11-29" Type="SCV" Version="1" SubmitterName="Variantyx, Inc." OrgID="506526" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22855961</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32582862</ID>
          </Citation>
          <Comment>This is a frameshift variant in the POLR3A gene (OMIM 614258). Biallelic pathogenic variants in this gene have been associated with autosomal recessive POLR3A-related disorders. This variant introduces a premature termination codon in exon 27 out of 31. It is expected to result in loss of function, which is a known disease mechanism for POLR3A (PMID: 22855961) (PVS1). This variant has been reported in the homozygous or compound heterozygous state in at least one affected individual (PMID: 32582862) (PM3_Supporting). This variant has a 0.01231% maximum allele frequency in non-founder control populations (https://gnomad.broadinstitute.org/), which is lower than expected for the prevalence of POLR3A-related disorders (PM2_Supporting). Based on the current evidence, this variant is classified as pathogenic for autosomal recessive POLR3A-related disorders.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Variantyx Assertion Criteria 2022</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/2zdwovk5/variantyx_assertion_criteria_2022.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POLR3A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_007055.4:c.3583del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">POLR3A-related disorders</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12247157</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6450301" SubmissionDate="2023-01-27" DateLastUpdated="2023-02-07" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="d6af352d-300c-4177-b24a-86a6e2d9233a" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV003761123" DateUpdated="2023-02-07" DateCreated="2023-02-07" Type="SCV" Version="1" SubmitterName="Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard" OrgID="506627" OrganizationCategory="laboratory" OrgAbbreviation="Broad RDG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-01-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The p.Asp1195fs variant in POLR3A has been reported in 2 individuals with POLR3A-related disorders (PMID: 32582862, 33879512) and has been identified in 0.01% (2/16252) of African/African American chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs747683665). Although this variant has been seen in the general population in a heterozygous state, its frequency is not high enough to rule out a pathogenic role. This variant has also been reported in ClinVar (Variation ID#: 684775) and has been interpreted as pathogenic by MyeliNeuroGene Lab (McGill University Health Center Research Institute) and Invitae. Of the 2 affected individuals, 1 was a compound heterozygote that carried a reported pathogenic variant in trans, which increases the likelihood that the p.Asp1195fs variant is pathogenic (VariationID: 449556; PMID: 32582862). This variant is predicted to cause a frameshift, which alters the protein‚Äôs amino acid sequence beginning at position 1195 and leads to a premature termination codon 47 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the POLR3A gene is an established disease mechanism in autosomal recessive POLR3A-related disorders. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic for autosomal recessive POLR3A-related disorders. ACMG/AMP Criteria applied: PVS1, PM3 (Richards 2015).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POLR3A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_007055.4(POLR3A):c.3583del</Name>
            <Name>p.Asp1195fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000010.11:g.77982665del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0011897" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12627697</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4251657" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="1629251|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002233866" DateUpdated="2024-02-20" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">32582862</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21855841</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25339210</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27612211</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30414627</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30450527</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 684775). This premature translational stop signal has been observed in individual(s) with leukodystrophy (PMID: 32582862). This variant is present in population databases (rs747683665, gnomAD 0.01%). This sequence change creates a premature translational stop signal (p.Asp1195Ilefs*47) in the POLR3A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in POLR3A are known to be pathogenic (PMID: 21855841, 25339210, 27612211, 30414627, 30450527).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POLR3A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000010.10:g.79742422del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="6450301" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0011897" MappingRef="MONDO">
        <MedGen CUI="C2676243" Name="Leukoencephalopathy-ataxia-hypodontia-hypomyelination syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1935629" TraitType="Disease" MappingType="Name" MappingValue="LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM" MappingRef="Preferred">
        <MedGen CUI="C2676243" Name="Leukoencephalopathy-ataxia-hypodontia-hypomyelination syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4251657" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1935629" TraitType="Disease" MappingType="Name" MappingValue="HLD7" MappingRef="Preferred">
        <MedGen CUI="C2676243" Name="Leukoencephalopathy-ataxia-hypodontia-hypomyelination syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5239735" TraitType="Disease" MappingType="Name" MappingValue="POLR3A-related disorders" MappingRef="Preferred">
        <MedGen CUI="None" Name="POLR3A-related disorder" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

